Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02728050
Title Filgrastim, Cladribine, Cytarabine and Mitoxantrone With or Without Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Washington
Indications

bone marrow cancer

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Sorafenib

Cladribine + Cytarabine + Filgrastim + Mitoxantrone

Age Groups: adult
Covered Countries USA


No variant requirements are available.